Fighting disease

From smallpox to AIDS, how the world has battled infectious diseases

If we are to save the world from the threat of infectious diseases, we need to learn the lessons of past outbreaks.

In 2013, the World Health Organisation declared antibiotic resistance was a threat to global health security. It can seem hard to believe that in the 21st century infectious diseases remain such a profound existential risk. But this declaration highlights the ever-lingering threat of infectious diseases and our dependence on antibiotics to stave off their impact on human and animal health and industry.

It also reminds us to appreciate antibiotics as one of many advances in infectious diseases and public health during the past century, and reflect on some of the greatest, still persistent, infectious disease challenges facing us today.

Here we explore our past and present struggles with four of the most significant infectious diseases human beings have faced, some of the progress we’ve made in prevention and treatment, and possible future directions.

Infectious disease deaths. Reprinted with permission from Macmillan Publishers Ltd: Nature. Paulson T. Epidemiology: a mortal foe. Nature 2013.
Infectious disease deaths. Reprinted with permission from Macmillan Publishers Ltd: Nature. Paulson T. Epidemiology: a mortal foe. Nature 2013.

Tuberculosis

Tuberculosis or TB has been responsible for the death of more people than any other infectious disease in history; over a billion deaths in the past 200 years. Its origin is unclear, but it infects a number of other species, including cattle.

Today, about a third of the world’s population is thought to be infected with TB, in its dormant form. This means the bacteria is present but it’s controlled by the immune system, the infected person has no symptoms, and it can’t be spread to others. The bacteria will reactivate in a small proportion of people and they may develop symptoms including fever, sweats, weight loss, fatigue, cough, and haemoptysis (coughing up blood).

TB occurs in every country, including Australia, but mostly occurs in people born in countries where TB is more common, due to the reactivation of dormant TB infection. Patients with weakened immune systems due to chemotherapy, HIV or other medical illnesses are at higher risk of TB.

In 2015, there were 10.4 million new cases of TB, and 1.8 million TB-related deaths around the world?, with the vast majority of cases in developing countries. The infection and death rate have been declining internationally since the early 1900s.

Long before the availability of treatment options, improvements in sanitation, housing, and vaccination led to a reduction in the rates of TB in some countries. But antibiotics made it a curable disease; without them, up to 70% of people with active infection die from TB.

But treatment is complicated, and typically involves taking four medications for two months, then two medications for a further four months. These medications are not without side effects, and can be poorly tolerated. Unfortunately, when medications are not taken or prescribed properly, the TB bacteria can become resistant to these treatments.

In recent years, drug-resistant TB has been documented all over the world, but is much more common in people previously treated for TB, and in Russia, China and India.

Treatment of resistant TB is much more complicated, takes longer, is more prone to failure, and often uses more toxic drugs. New rapid tests can diagnose TB, and whether or not the bacteria will be resistant to our first-line drugs.

A vaccine for TB has been available for around a century, but is most effective in preventing severe TB infection in children. The vaccine’s efficacy is much less clear in adults.

Despite advances in treatment, tuberculosis continues to occur disproportionately in the developing world. Although progress is being made, ongoing and increased political and financial support is essential to ensure coordinated diagnosis, surveillance and care strategies, and universal access to these. Similarly, continued investment is needed for the development of new tools to detect and treat TB.

Smallpox

Smallpox was caused by the variola virus, which plagued humanity for millennia and had a lasting impact on human history. As late as the 1960s, smallpox was still endemic in Asia and Africa, with an estimated two million deaths occurring annually.

Smallpox was spread easily between people by sneezing or shared contact, leading swiftly to the characteristic disfiguring pustular lesions on the skin. The disease was severe, with about 30% of affected people dying, while the rest were left with complications associated with infection. These included a multitude of scars, blindness, infections and arthritis.

Those who survived, however, were generally protected from reinfection. Building on observations that milkmaids were protected from smallpox, Edward Jenner, an 18th century British physician, developed and popularised a technique called “vaccination” whereby he deliberately inoculated a patient with cowpox, a closely related virus the milkmaids were exposed to. This led to protection from smallpox.

While a popular origin story, alternative approaches to protection, such as inhaling dried smallpox lesions, had likely been practised in China and India for many years previously, and had already been introduced into the United Kingdom. However, inoculation with smallpox came with a risk of severe infection in a significant number of recipients, and Jenner’s safer approach was adopted for larger scale immunisation programs.

In 1980, smallpox became the first, and so far only, human infectious disease to be declared eradicated by the World Health Organisation. This came about via a coordinated international response, led by an Australian microbiologist, Frank Fenner. This involved mass-vaccination, along with public health surveillance and preventative measures, which aimed to educate communities, and identify and contain individual cases.

The last case of smallpox was reported in Somalia in 1977, with the unfortunate death of medical photographer Janet Parker in 1978 serving as a final warning of this deadly condition.

Smallpox may be gone as a disease, but the variola virus controversially remains, kept secure in laboratories in Russia and the US. Concern has emerged about the prospect of smallpox as a weapon of bioterrorism. The impact of such an event could be devastating, given people are no longer routinely immunised against smallpox.

HIV/AIDS

In the early 1980s, a small number of gay men in the United States started presenting with unusual infections, previously only seen in people with severe immune deficiencies. Over the subsequent years, the human immunodeficiency virus or HIV was discovered, and its global burden was recognised.

The virus, which had most likely originated in primates in Africa, had probably been infecting humans for close to a century, and had spread across the globe. Untreated HIV causes a slow destruction of the infected person’s immune system, leading to a plethora of opportunistic infections and cancers, known as the acquired immunodeficiency syndrome or AIDS.

Without treatment, almost all people with HIV progress to AIDS, and die. At its peak in the 1990s, around 1,000 Australians a year died from HIV/AIDS.

AIDS awareness painting on wall in Chimoio town, Mozambique. The text reads:
AIDS awareness painting on wall in Chimoio town, Mozambique. The text reads: "Be careful, always use a condom". (Photo: Ton RulkensFlickr)

HIV/AIDS mobilised western communities to act like never before. In Australia, a grassroots campaign led by communities most deeply affected resulted in a number of public health interventions and legislative changes. This included safe sex campaigns, needle exchange programs, and mandatory condom use and STI testing for commercial sex workers.

These changes led to reductions in rates of new HIV cases, while global investment in research and public health led to the development of “antiretroviral” drugs, which stopped the virus from replicating, helped control HIV infection, and markedly reduced the risk of progression to AIDS.

To date, about 40 million people have died from AIDS, and an estimated 36.7 million are living with HIV. Nevertheless, most people affected by HIV in western countries live a long and healthy life.

Although an effective vaccine for HIV is not available, progress is being made in diagnosis, reducing transmission and improving the health of those affected.

Treating those with HIV to a point where the virus isn’t detectable in their blood reduces the possibility of onward transmission by 90-95%. And it leads to numerous individual health benefits for the infected individual. In contrast, uninfected people at high risk of contracting the virus can take antiviral medications known as pre-exposure prophylaxis that prevent infection. These have shown to be highly effective if taken properly.

There are hopes these treatments will end the epidemic by 2030.

Influenza

It’s easy to forget about the danger of influenza. In most cases, this virus is responsible for a respiratory illness of varying severity that generally doesn’t require treatment. However, influenza has been responsible for more deaths in the last century than HIV/AIDS.

Usually, seasonal influenza outbreaks occur annually and affect around four million people, with about 250,000 deaths worldwide. Typically older patients, with pre-existing illnesses such as heart failure or chronic lung disease, and pregnant women are at the greatest risk of death.

Many people have a degree of immunity, due to vaccination or previous infection. It’s worth noting that although safe, the influenza vaccine is imperfect; it’s developed using strains of influenza virus circulating in winter, in the opposite hemisphere, and is about 50% effective at preventing infection. But vaccination is still an important strategy to protect those at risk of most severe infection. It reduces hospital admission and symptomatic infection.

Occasionally, an influenza virus not usually seen in humans is transmitted from its reservoir in aquatic birds, poultry or pigs, to humans. As a consequence, those exposed have no natural immunity, and are not protected by the vaccine at all. If this virus evolves to readily infect and spread between humans, it can have devastating consequences.

In the last century, this has happened several times, with numerous fatalities. The Spanish influenza pandemic of 1918 led to the deaths of more than 40 million people; more than double the number of fatalities in the First World War in the preceding four years. It progressively spread around the globe, with the modernisation of transport and trade systems, and mass-movement of military troops.

In more recent times, smaller outbreaks have occurred, with bird flu and swine flu. There is an ever-lingering threat of a repeat influenza pandemic, due to the industrial scale farming of chickens and pigs, that are also susceptible to infection and the close proximity of humans to these animals.

Due to the rapid and fluid movement of people around the globe for business and leisure, a new pandemic virus could easily be transported around the world. In recent years, countries have stockpiled influenza medications and vaccines in preparation for a possible influenza pandemic.

These are only four of the infectious diseases that have shaped the last century. In reality, there are a number that could have been included in this list of threats including polio, malaria, cholera and syphilis.

Each of these diseases is very different, and as such, our responses to them have been very different too. In part this is because quite different organisms cause these infections, but it’s also because the social context in which diseases happen is critical.

If we are to save the world from the threat of infectious diseases, we need to learn the lessons of past outbreaks, including the value of international collaboration, perseverance and commitment to humanity.

This article was first published on The Conversation.

We welcome your comments at letters@scroll.in.
Sponsored Content BY 

How sustainable farming practices can secure India's food for the future

India is home to 15% of the world’s undernourished population.

Food security is a pressing problem in India and in the world. According to the Food and Agriculture Organization of the UN (FAO), it is estimated that over 190 million people go hungry every day in the country.

Evidence for India’s food challenge can be found in the fact that the yield per hectare of rice, one of India’s principal crops, is 2177 kgs per hectare, lagging behind countries such as China and Brazil that have yield rates of 4263 kgs/hectare and 3265 kgs/hectare respectively. The cereal yield per hectare in the country is also 2,981 kgs per hectare, lagging far behind countries such as China, Japan and the US.

The slow growth of agricultural production in India can be attributed to an inefficient rural transport system, lack of awareness about the treatment of crops, limited access to modern farming technology and the shrinking agricultural land due to urbanization. Add to that, an irregular monsoon and the fact that 63% of agricultural land is dependent on rainfall further increase the difficulties we face.

Despite these odds, there is huge potential for India to increase its agricultural productivity to meet the food requirements of its growing population.

The good news is that experience in India and other countries shows that the adoption of sustainable farming practices can increase both productivity and reduce ecological harm.

Sustainable agriculture techniques enable higher resource efficiency – they help produce greater agricultural output while using lesser land, water and energy, ensuring profitability for the farmer. These essentially include methods that, among other things, protect and enhance the crops and the soil, improve water absorption and use efficient seed treatments. While Indian farmers have traditionally followed these principles, new technology now makes them more effective.

For example, for soil enhancement, certified biodegradable mulch films are now available. A mulch film is a layer of protective material applied to soil to conserve moisture and fertility. Most mulch films used in agriculture today are made of polyethylene (PE), which has the unwanted overhead of disposal. It is a labour intensive and time-consuming process to remove the PE mulch film after usage. If not done, it affects soil quality and hence, crop yield. An independently certified biodegradable mulch film, on the other hand, is directly absorbed by the microorganisms in the soil. It conserves the soil properties, eliminates soil contamination, and saves the labor cost that comes with PE mulch films.

The other perpetual challenge for India’s farms is the availability of water. Many food crops like rice and sugarcane have a high-water requirement. In a country like India, where majority of the agricultural land is rain-fed, low rainfall years can wreak havoc for crops and cause a slew of other problems - a surge in crop prices and a reduction in access to essential food items. Again, Indian farmers have long experience in water conservation that can now be enhanced through technology.

Seeds can now be treated with enhancements that help them improve their root systems. This leads to more efficient water absorption.

In addition to soil and water management, the third big factor, better seed treatment, can also significantly improve crop health and boost productivity. These solutions include application of fungicides and insecticides that protect the seed from unwanted fungi and parasites that can damage crops or hinder growth, and increase productivity.

While sustainable agriculture through soil, water and seed management can increase crop yields, an efficient warehousing and distribution system is also necessary to ensure that the output reaches the consumers. According to a study by CIPHET, Indian government’s harvest-research body, up to 67 million tons of food get wasted every year — a quantity equivalent to that consumed by the entire state of Bihar in a year. Perishables, such as fruits and vegetables, end up rotting in store houses or during transportation due to pests, erratic weather and the lack of modern storage facilities. In fact, simply bringing down food wastage and increasing the efficiency in distribution alone can significantly help improve food security. Innovations such as special tarpaulins, that keep perishables cool during transit, and more efficient insulation solutions can reduce rotting and reduce energy usage in cold storage.

Thus, all three aspects — production, storage, and distribution — need to be optimized if India is to feed its ever-growing population.

One company working to drive increased sustainability down the entire agriculture value chain is BASF. For example, the company offers cutting edge seed treatments that protect crops from disease and provide plant health benefits such as enhanced vitality and better tolerance for stress and cold. In addition, BASF has developed a biodegradable mulch film from its ecovio® bioplastic that is certified compostable – meaning farmers can reap the benefits of better soil without risk of contamination or increased labor costs. These and more of the company’s innovations are helping farmers in India achieve higher and more sustainable yields.

Of course, products are only one part of the solution. The company also recognizes the importance of training farmers in sustainable farming practices and in the safe use of its products. To this end, BASF engaged in a widespread farmer outreach program called Samruddhi from 2007 to 2014. Their ‘Suraksha Hamesha’ (safety always) program reached over 23,000 farmers and 4,000 spray men across India in 2016 alone. In addition to training, the company also offers a ‘Sanrakshan® Kit’ to farmers that includes personal protection tools and equipment. All these efforts serve to spread awareness about the sustainable and responsible use of crop protection products – ensuring that farmers stay safe while producing good quality food.

Interested in learning more about BASF’s work in sustainable agriculture? See here.

This article was produced by the Scroll marketing team on behalf of BASF and not by the Scroll editorial team.